Purchases and Sales Made in Q4 2023 in Essa Pharma Inc. (EPIX)
This table provides information about the institutional ownership of Essa Pharma Inc. (EPIX) during Q4 2023. The information is specifically focused on institutions that hold shares of ESSA Pharma Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Rtw Investments, LP
New York, NY |
BUY
|
- |
2.3MNew |
$6.3M - $16.9M
|
2.3M
$3.77M
|
|
|
Feb 14, 2024
Q4 2023
|
Janus Henderson Group PLC
London, X0 |
BUY
|
- |
1.09MNew |
$2.99M - $8.01M
|
1.09M
$1.79M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
258K+ 4714.74% |
$707K - $1.9M
|
264K
$432K
|
|
|
Feb 14, 2024
Q4 2023
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
BUY
|
- |
93.4K+ 8.96% |
$256K - $686K
|
1.14M
$1.86M
|
|
|
Feb 14, 2024
Q4 2023
|
Soleus Capital Management, L.P.
Greenwich, CT |
BUY
|
- |
40.5K+ 0.95% |
$111K - $298K
|
4.33M
$7.1M
|
|
|
Feb 14, 2024
Q4 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
BUY
|
- |
31.6K+ 18.81% |
$86.6K - $232K
|
200K
$327K
|
|
|
Feb 14, 2024
Q4 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
29.3K+ 1954.41% |
$80.2K - $215K
|
30.8K
$50.5K
|
|
|
Feb 13, 2024
Q4 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
24.2KNew |
$66.4K - $178K
|
24.2K
$39.7K
|
|
|
Feb 13, 2024
Q4 2023
|
American Century Companies Inc
Kansas City, MO |
BUY
|
- |
20KNew |
$54.9K - $147K
|
20K
$32.9K
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
8.73K+ 0.21% |
$23.9K - $64.2K
|
4.19M
$6.87M
|
|
|
Feb 13, 2024
Q4 2023
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
7.82K+ 41.07% |
$21.4K - $57.5K
|
26.9K
$44K
|
|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
BUY
|
- |
4.73K+ 2866.67% |
$13K - $34.8K
|
4.9K
$8.03K
|
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
3.9K+ 0.09% |
$10.7K - $28.6K
|
4.19M
$6.87M
|
|
|
Feb 02, 2024
Q4 2023
|
Simplex Trading, LLC
|
BUY
|
- |
513+ 13.98% |
$1.41K - $3.77K
|
4.18K
$6.86K
|
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 15, 2024
Q4 2023
|
Barclays PLC
London, X0 |
SELL
|
- |
-317- 24.61% |
$869 - $2.33K
|
971
$1.59K
|
|
|
Feb 12, 2024
Q4 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-6K- 50.0% |
$16.4K - $44.1K
|
6K
$9.84K
|
|
|
Feb 12, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-29.4K- 99.93% |
$80.6K - $216K
|
21
$34.4
|
|
|
Feb 14, 2024
Q4 2023
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-30.7K- 73.3% |
$84.1K - $226K
|
11.2K
$18.3K
|
|
|
Feb 13, 2024
Q4 2023
|
Cibc World Market Inc.
Toronto, A6 |
SELL
|
- |
-37.4K- 25.11% |
$103K - $275K
|
112K
$183K
|
|
|
May 16, 2024
Q4 2023
|
Connective Capital Management, LLC
Palo Alto, CA |
SELL
|
- |
-84.6KClosed |
$232K - $622K
|
0
$0
|
|
|
Feb 14, 2024
Q4 2023
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-937K- 22.31% |
$2.57M - $6.89M
|
3.26M
$5.35M
|